WolverHeme Happy Hour

35 Folgen

1. Episode 14: A Quantum Leap in AML Treatment? Dissecting Quizartinib Data with Dr. Dale Bixby

   Vom: 9.5.2023
2. Episode 13: You get blinatumomab! You get blinatumomab!

   Vom: 24.2.2023
3. Episode 12: Tinder for T Cells - Bispecifics in DLBCL

   Vom: 8.2.2023
4. Episode 11: "Olu the Drunk Snowman" - IDH inhibitors in R/R AML with Dr. Jill Lykon

   Vom: 21.1.2023
5. Episode 10: ASH Recap Part 2 - Papa Heme + WolverHeme

   Vom: 21.12.2022
6. Episode 9: ASH Recap Part 1 - Dauno-Double Trouble

   Vom: 14.12.2022
7. Episode 8: Pulling the Goalie on FLT3 Inhibitor Use in AML - A Discussion with Dr. Dale Bixby

   Vom: 23.11.2022
8. Episode (3+)7: Straight Outta Roswell - OG AML Data

   Vom: 7.10.2022
9. Episode 6: Dr. StrangeDrug or: How I Learned to Stop Worrying and Love the Asparaginase

   Vom: 21.7.2022
10. Episode 5: IDH Inhibitors in AML: not so AGILE

    Vom: 3.6.2022
11. Episode 4: All Aboard the Oncology StewardSHIP

    Vom: 27.5.2022
12. Episode 3.2: Ranting About Rituximab in Acute Lymphoblastic Leukemia

    Vom: 22.4.2022
13. Episode 3.1: History of Acute Lymphoblastic Leukemia Treatment and Building the BFM Backbone

    Vom: 22.4.2022
14. Episode 2: We Don't Talk About Rylaze

    Vom: 18.3.2022
15. Episode 1: Surrogate Endpoints in AML

    Vom: 11.3.2022